Medical News

RSS

Doctations launches blog to improve healthcare

Doctations, Inc., an innovative leader in applying Internet technology to improve healthcare, today announced the launch of its new DocPatient blog. Weekly postings to the blog site by company executives and thought leaders will address timely healthcare related topics, express expert opinions and pose provocative questions intended to inform the community, stimulate constructive dialogue and promote healthcare improvement.

29 Sep 2009

Synta commences Phase 1/2 clinical study of novel Hsp90 inhibitor in hematologic malignancies

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical study of its novel heat shock protein 90 (Hsp90) inhibitor, STA-9090 in hematologic malignancies with a once-a-week dosing schedule.

29 Sep 2009

iposture launches posture improvement device for golfers

Memphis-based neurologist Moacir Schnapp, M.D., creator of the iPosture, today announced the launch of his posture improvement device for golfers – the iPosture Golf-Pro.

29 Sep 2009

Acrux reports Phase III trial results evaluating AXIRON for testosterone deficiency

Australian company, Acrux, today announced positive results from a Phase III trial evaluating the safety and efficacy of AXIRON™ in 155 men with testosterone deficiency (hypogonadism), across 26 sites in six countries.

29 Sep 2009

Aurora Breast MRI and Clear Channel Radio join to support The Wellness Community fundraiser

Aurora Breast MRI of Sarasota today announced it has partnered with Clear Channel Radio for a fundraising effort to benefit The Wellness Community of Southwest Florida. The fundraiser, titled “Change for Change,” will consist of a series of breast cancer awareness messages throughout the month of October to encourage donations at area “Change for Change” locations.

29 Sep 2009

Local officials address long-term costs associated with employee and retiree health care

About 49 percent of the nations’ cities, counties and townships expect less revenue in 2010, and 21 percent expect fewer employees, according to a new survey.

29 Sep 2009

1-800-DENTIST launches nationwide smile makeover contest

As an advocate of regular dental care, 1-800-DENTIST® understands that many people can't afford the dentistry they need. That's why the nation's leading free resource for consumers in search of a dentist has launched a nationwide $30,000 smile makeover contest called "My Smile Bites." To enter, contestants must upload a personal video showing what's wrong with their smile, explaining how these problems affect their lives. Video submissions will be accepted through November 10, 2009 noon PST.

29 Sep 2009

Multiple Sclerosis Society of Canada invites schools to participate in the 32nd MS Read-A-Thon

Multiple Sclerosis Society of Canada, Quebec Division is happy to announce the 32nd edition of the MS Read-A-Thon. This event invites students in elementary and secondary schools across the province to participate in an enjoyable activity that gives them a chance to develop their philanthropic qualities while stimulating their interest in reading.

29 Sep 2009

New Jersey hopsital chooses JAOtech's embedded Smart Terminals

Holy Name hospital of Teaneck, New Jersey has selected JAOtech Smart Terminals for its second generation bedside entertainment and communication system.

29 Sep 2009

Scarab Genomics releases new E. Coli strain

ScarabXpress is the latest strain in the multiple-deletion series (MDS) of Scarab Genomics Clean Genome® E. coli. Based on the MDS™42 strain, ScarabXpress T7lac contains a chromosomal copy of the T7 RNA polymerase gene expressed from a unique, tightly controlled lac promoter.

29 Sep 2009

Elan Corporation intends to offer senior fixed rate notes due 2016

Elan Corporation, plc today announced that its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp., intend to offer, subject to market conditions, US$600 million in aggregate principal amount of senior fixed rate notes due 2016 (the “New Notes”).

29 Sep 2009

Most Danes support use of GM plants for pharmaceutical purposes

An international survey shows that most Danes support using GM plants for production of pharmaceuticals. In this respect Danes are in line with citizens from the U.S., Israel, Spain, Poland and the Czech Republic.

29 Sep 2009

Spectranetics seeks FDA clearance for treating in-stent restenosis in the legs

Spectranetics Corporation today announced that it has filed a 510(k) application with the Food and Drug Administration seeking clearance for the treatment of in-stent restenosis (ISR) in the legs with its commercially available peripheral atherectomy products. ISR is caused by the re-growth of tissue within the stent, known as neointimal hyperplasia, which can lead to blockages in the affected leg artery.

29 Sep 2009

CEO Cancer Gold Standard accreditation for State Farm

State Farm has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.

29 Sep 2009

Newsweek ranks Medtronic 2nd in the healthcare industry sector

Recognizing its leadership in meeting the needs of economic, environmental, and social stakeholders, Medtronic, Inc. (NYSE: MDT) has been named a member company in the Dow Jones Sustainability Index (DJSI) for North America and the FTSE4Good Index Series.

29 Sep 2009

Dynavax commences Phase 3 trial for HEPLISAV hepatitis B vaccine

Dynavax Technologies Corporation (Nasdaq:DVAX) today announced the initiation of a Phase 3 registration trial for HEPLISAVTM hepatitis B vaccine in individuals with chronic kidney disease. A second registration trial, a Phase 3 lot-to-lot consistency trial, is expected to begin in early 2010. HEPLISAV is an investigational adult hepatitis B vaccine designed to provide increased, rapid protection with fewer doses than current licensed vaccines.

29 Sep 2009

Repros Therapeutics receives further clarification on the Full Clinical Hold status of Proellex

Repros Therapeutics today announced that the Company has received further clarification from the Food and Drug Administration (FDA) on the Full Clinical Hold status of Proellex.

29 Sep 2009

2009 Mini-Psych School Program dispels myths surrounding mental illness

The Mental Illness Awareness Week is coming up, from October 4 to 10. On this occasion, Joseph Rochford, Ph.D., Director of the Academic Affairs at the Douglas Mental Health University Institute, presents his top ten list of myths about mental illness.

29 Sep 2009

IP Advocate founder to speak on commercialization barriers faced by university faculty inventors

Speaking of the then-divided Berlin, former President Reagan famously admonished Soviet leader Gorbachev to “tear down this wall.” In a similar spirit, IP Advocate founder Dr. Renee Kaswan is calling on the university technology transfer system to remove the barriers that keep innovations from moving swiftly into the marketplace.

29 Sep 2009

First edition: September 29, 2009

The Finance Committee will resume work today on its mark up of its health bill -- with some fireworks likely on the public plan and other wild cards.

29 Sep 2009

Medical News

Doctations launches blog to improve healthcare

Synta commences Phase 1/2 clinical study of novel Hsp90 inhibitor in hematologic malignancies

iposture launches posture improvement device for golfers

Acrux reports Phase III trial results evaluating AXIRON for testosterone deficiency

Aurora Breast MRI and Clear Channel Radio join to support The Wellness Community fundraiser

Local officials address long-term costs associated with employee and retiree health care

1-800-DENTIST launches nationwide smile makeover contest

Multiple Sclerosis Society of Canada invites schools to participate in the 32nd MS Read-A-Thon

New Jersey hopsital chooses JAOtech's embedded Smart Terminals

Scarab Genomics releases new E. Coli strain

Elan Corporation intends to offer senior fixed rate notes due 2016

Most Danes support use of GM plants for pharmaceutical purposes

Spectranetics seeks FDA clearance for treating in-stent restenosis in the legs

CEO Cancer Gold Standard accreditation for State Farm

Newsweek ranks Medtronic 2nd in the healthcare industry sector

Dynavax commences Phase 3 trial for HEPLISAV hepatitis B vaccine

Repros Therapeutics receives further clarification on the Full Clinical Hold status of Proellex

2009 Mini-Psych School Program dispels myths surrounding mental illness

IP Advocate founder to speak on commercialization barriers faced by university faculty inventors

First edition: September 29, 2009

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News